The history of the erectile dysfunction drug presents a challenging picture for those considering investment. While the initial release generated significant profits, the lapse of its intellectual property protection opened the avenue to off-brand competitors, dramatically reducing market share. This creates a unique risk for pharmaceutical compani

The emergence of so-called "Premium Gambler's The Pill" – often referring to exceptionally high doses ordered by rogue physicians – represents a particularly alarming trend. While typical dosages of Sildenafil are intended for treating erectile dysfunction safely in most men, these significantly elevated amounts pose a significant risk to cardi